Search Results - "M Keyaerts"

Next-generation muscle-directed gene therapy by in silico vector design by Sarcar, S., Tulalamba, W., Rincon, M. Y., Tipanee, J., Pham, H. Q., Evens, H., Boon, D., Samara-Kuko, E., Keyaerts, M., Loperfido, M., Berardi, E., Jarmin, S., In’t Veld, P., Dickson, G., Lahoutte, T., Sampaolesi, M., De Bleser, P., VandenDriessche, T., Chuah, M. K.

“…There is an urgent need to develop the next-generation vectors for gene therapy of muscle disorders, given the relatively modest advances in clinical trials…”
Get full text

Phase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients by Keyaerts, M., Xavier, C., Everaert, H., Vaneycken, I., Fontaine, C., Decoster, L., Vanhoeij, M., Caveliers, V., Lahoutte, T.

Get full text

Antigen-presenting cell-targeted lentiviral vectors do not support the development of productive T-cell effector responses: implications for in vivo targeted vaccine delivery by Goyvaerts, C, De Vlaeminck, Y, Escors, D, Lienenklaus, S, Keyaerts, M, Raes, G, Breckpot, K

“…Targeting transgene expression specifically to antigen-presenting cells (APCs) has been put forward as a promising strategy to direct the immune system towards…”
Get full text

Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer by Lecocq, Q., Debie, P., Puttemans, J., Awad, R. M., De Beck, L., Ertveldt, T., De Vlaeminck, Y., Goyvaerts, C., Raes, G., Keyaerts, M., Breckpot, K., Devoogdt, N.

“…Recent advancements in the field of immune-oncology have led to a significant increase in life expectancy of patients with diverse forms of cancer, such as…”
Get full text

Port-site metastasis after explorative laparoscopy for an incidental appendiceal mucinous cystadenocarcinoma detected with FDG PET/CT by Ceulemans, G, Keyaerts, M, Willems, S, Simoens, Ch, Ilsen, B, Everaert, H

“…A 62-year old female with a history of appendix carcinoma came to our department for an 18 F FDG PET/CT to further characterize a subcutaneous fixed small mass…”
Get full text

Agenesis of the pubic symphysis detected with SPECT-CT by Ceulemans, G, Keyaerts, M, De Maeseneer, M, Verdries, D, Everaert, H

“…The pelvis is composed of 3 paired bones (ischiac, pubic and iliac bones) and the sacrum. Any part of the pelvis can be congeni tally absent, but the sacrum is…”
Get full text

Selective spleen SPECT/CT by Ceulemans, G, Sermeus, A, Verdries, D, Keyaerts, M, Ilsen, B, Kichouch, M, De Ridder, M, Everaert, H

“…During virtual colonoscopy, performed for severe constipation in a 77-year-old male, a mass (22 x 51 mm) was detected in the tail of the pancreas. The CT…”
Get full text

Erdheim-Chester disease detected with 99MTC MDP bone SPECT/CT by G Ceulemans, M Keyaerts, L Verbruggen, A Hoorens, C Boulet, D Verdries, M De Maeseneer, B Ilsen, H Everaert

“…Erdheim-Chester disease (ECD) is a rare non-Langerhans’ cell histiocytosis. Mild but permanent juxta-articular bone pain in mainly knees and ankles is the most…”
Get full text

Labeling of Anti-HER2 Nanobodies with Astatine-211: Optimization and the Effect of Different Coupling Reagents on Their in Vivo Behavior by Dekempeneer, Yana, Bäck, Tom, Aneheim, Emma, Jensen, Holger, Puttemans, Janik, Xavier, Catarina, Keyaerts, Marleen, Palm, Stig, Albertsson, Per, Lahoutte, Tony, Caveliers, Vicky, Lindegren, Sture, D’Huyvetter, Matthias

“…The use of nanobodies (Nbs) as vehicles in targeted alpha therapy (TAT) has gained great interest because of their excellent properties. They combine high in…”
Get full text

85TiPPhase II trial of HER2-PET/CT using 68Ga-anti-HER2 VHH1 for characterization of HER2 presence in brain metastases of breast cancer patients by Keyaerts, M, Xavier, C, Everaert, H, Vaneycken, I, Fontaine, C, Decoster, L, Vanhoeij, M, Caveliers, V, Lahoutte, T

Get full text

Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab by Awada, G., Özdemir, I., Schwarze, J.K., Daeninck, E., Gondry, O., Jansen, Y., Seremet, T., Keyaerts, M., Everaert, H., Neyns, B.

Get full text

Development of LAG-3 nanobodies as potent cancer imaging tracers by Lecocq, Q., Awad, R.M., Zeven, K., De Vlaeminck, Y., de Mey, W., Debie, P., Puttemans, J., Goyvaerts, C., Raes, G., Keyaerts, M., Devoogdt, N., Breckpot, K.

Get full text

93MO Optimal 18F-FDG PET/CT (FDG-PET) cut-off for pathological complete response (pCR) prediction in HER2-positive [HER2+] early breast cancer (EBC) patients (pts) treated with neoadjuvant trastuzumab (T) and pertuzumab (P) in PHERGain trial by Gebhart, G., Keyaerts, M., Guiot, T., Flamen, P., Ruiz Borrego, M., Stradella, A., Bermejo De Las Heras, B., Escriva de Romani, S., Calvo-Martinez, L., Ribelles Entrena, N., Martinez, N., Albacar Miro, C.R., Colleoni, M.A., Atienza de Frutos, M., Sampayo-Cordero, M., Cortés, J., Perez Garcia, J.M., Llombart Cussac, A.

Get full text

168P Characterization of the lung tumor microenvironment upon anti-PD-L1 therapy reveals an ambiguous role for TNF-α by De Ridder, K., Locy, H., Piccioni, E., Ibarra Zuazo, M., Awad, R.M., Verhulst, S., van Bulck, M., De Vlaeminck, Y., Lecocq, Q., Reijmen, E., De Mey, W., De Beck, L., Ertveldt, T., Pintelon, I., Timmermans, J-P., Escors, D., Keyaerts, M., Breckpot, K., Goyvaerts, C.

Get full text

101P Predictors of 18F-fluorodeoxyglucose (F) positron-emission tomography (PET)-driven disease detection in patients (pts) with HER2[+] early breast cancer (EBC). A substudy of the PHERGain trial by Llombart Cussac, A., Prat, A., Pérez-García, J.M., Mateos, J., Pascual, T., Escrivà-De-Romani, S., Stradella, A., Ruiz-Borrego, M., Bermejo De Las Heras, B., Keyaerts, M., Sampayo-Cordero, M., Malfettone, A., Cortés, R., Galván, P., Cortés, J., Gebhart, G.

Get full text

21PBaseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab by Awada, G, Özdemir, I, Schwarze, J K, Daeninck, E, Gondry, O, Jansen, Y, Seremet, T, Keyaerts, M, Everaert, H, Neyns, B

Get full text

16.06 by Lauwers, R., Gallez, C., Franken, P., Vanhove, C., Droogmans, S., Caveliers, V., Keyaerts, M., Tchouate, O., Camu, F., Bossuyt, A., Lahoutte, T.

Get full text

16.06: Effect of anesthesia on left ventricular function in rat, assessment by 99mTc-MIBI pinhole gated SPECT by Lauwers, R., Gallez, C., Franken, P., Vanhove, C., Droogmans, S., Caveliers, V., Keyaerts, M., Tchouate, O., Camu, F., Bossuyt, A., Lahoutte, T.

Get full text

The role of chemotherapy in the treatment of low-grade glioma. A review of the literature by Neyns, Bart, Sadones, Jan, Chaskis, Cristo, De Ridder, Mark, Keyaerts, Marleen, Veld, Peter In't, Michotte, Alex

“…Low-grade gliomas (LGG) are a group of uncommon neuroglial tumors of the central nervous system. They are characterized by a grade I or II according to the WHO…”
Get more information

Erdheim-Chester disease detected with 99mTc MDP bone SPECT/CT by Ceulemans, G, Keyaerts, M, Verbruggen, L, Hoorens, A, Boulet, C, Verdries, D, De Maeseneer, M, Ilsen, B, Everaert, H

“…Erdheim-Chester disease (ECD) is a rare non-Langerhans' cell histiocytosis. Mild but permanent juxta-articular bone pain in mainly knees and ankles is the most…”
Get more information